Premium
Prescribing in COVID‐19 patients: Should we take into account inflammation?
Author(s) -
Marzolini Catia,
Battegay Manuel,
Sendi Parham,
Back David J.
Publication year - 2021
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/bcp.14524
Subject(s) - medicine , drug , pharmacology , cyp3a4 , molecular pharmacology , inflammation , clinical pharmacology , pharmacokinetics , covid-19 , clinical trial , disease , bioinformatics , intensive care medicine , immunology , cytochrome p450 , receptor , biology , metabolism , infectious disease (medical specialty)